explore -WSS

explore

author：fashion 2025-10-01 17:20:19 - browse：4

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Health Care Service Corp to buy Cigna Medicare Advantage plans

WSS

Will the FTC rein in IQVIA's health data empire?

Biogen says it will cut costs by $700 million, slash 1,000 jobs

CDC Director Mandy Cohen on transparency, trust, and health

In the gardens at Boston Children's Hospital, families find sanctuary

How doctors’ personal politics affect patients

A new crop of companies is reshaping the health data economy

explore

explore

knowledge

In age of alternative facts, a scholarly course on calling out crap

Why patients can’t get everything they want on drug pricing

Psychedelics group wrestles with new pharma identity

A new crop of companies is reshaping the health data economy

Alkermes shareholders re

Biogen says it will cut costs by $700 million, slash 1,000 jobs

State Dept. review finds Biden bears some blame for Afghanistan failures

Philips to halt sales of sleep apnea machines in U.S.

George Santos makes 1st court appearance after pleading not guilty to 13 counts

New clues to why women have higher risk of autoimmune disorders

focus

Dems pitch expanding Medicare power to negotiate drug prices

How generative AI ratchets up security threats for health systems

Biogen walks away from Aduhelm, years after polarizing approval

Why Medicare shouldn’t cover every FDA

Search called off for baby washed away in Pennsylvania flash flood

Will the FTC rein in IQVIA's health data empire?

knowledge

leisure time

hotspot

explore